Anemia News and Research

RSS

Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.

Combining medications often best strategy to battle rheumatoid arthritis

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality.

19 Nov 2007

Human health, agriculture and the environment to benefit from bioengineering project at the University of Kent

Martin Warren, Professor of Biochemistry at the University of Kent’s Department of Biosciences, has been awarded over £750,000 from the Biotechnology and Biological Sciences Research Council for a study into biochemical pathways that could ultimately lead to improved health benefits for humans, as well as the development of important new technologies and products for agriculture and bioremediation (the use of plants or microorganisms to clean up pollution or contaminated material).

19 Nov 2007

New anemia measure predicts risk of death in dialysis patients

A new indicator of variations in hemoglobin level over time is a strong predictor of the risk of death among patients receiving dialysis for end-stage renal disease (ESRD), reports a study in the December Journal of the American Society of Nephrology.

15 Nov 2007

FDA strengthens warnings for erythropoiesis-stimulating agents

The U.S. Food and Drug Administration has approved revised boxed warnings and other safety-related product labeling changes for erythropoiesis-stimulating agents (ESAs), which treat certain types of anemia.

13 Nov 2007

Chronic kidney disease common in U.S. - obesity, diabetes, hypertension and aging population contribute to increase

There is a high prevalence of chronic kidney disease in the United States, which has risen over the past decade, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

6 Nov 2007

Minority patients prefer optical colonoscopy for colorectal cancer screening

The clinical importance of colorectal cancer screening is well established, however the majority of eligible people do not undergo screening tests.

2 Nov 2007

Somalia experiencing huge increase in cases of visceral leishmaniasis

The international humanitarian organization Medecins Sans Frontières has witnessed a dramatic increase in the number of patients with the parasitic disease visceral leishmaniasis ("kala azar") admitted to its treatment center in Somalia.

31 Oct 2007

Blood group O may be the key to a cure for malaria

New research from Scotland has led to a discovery which may bring a cure for malaria a step closer.

31 Oct 2007

New treatment option studied for bladder cancer

A chemotherapy regimen for patients with advanced bladder cancer who aren't eligible for standard treatment is under study at the Medical College of Georgia.

29 Oct 2007

Stem cells from a person's own umbilical cord effectively treat blood and immune disorders, juvenile diabetes

Two separate data abstracts displayed at the annual scientific meeting of the AABB - an international association of medical professionals and institutions focused on transfusion, transplantation and cellular therapy - highlight the increasing therapeutic use of autologous (one's own) cord blood stem cells for transplant and regenerative medicine, including treatments for blood and immune disorders, juvenile diabetes and neurological repair.

22 Oct 2007

New insight into mechanisms by which E. coli colonize the intestines

Food poisoning caused by the bacteria enterohemorrhagic Eschericia coli (EHEC) O157:H7A results in severe abdominal cramps and bloody diarrhea.

19 Oct 2007

Early intervention dramatically improves outcomes for new dialysis patients

A program of education, close medical follow-up, and self-empowerment for patients with end-stage renal disease (ESRD) newly starting dialysis, reduces complications and improves outcomes - including significant reductions in mortality and hospitalization rates, reports a study in the November Clinical Journal of the American Society of Nephrology.

19 Oct 2007

Capsule endoscopy finds undiagnosed Crohn's disease

A small capsule that takes "snapshots" of the small intestine as it moves through the digestive tract helped doctors spot cases of Crohn's disease that had gone undiagnosed for up to 15 years, according to researchers at Wake Forest University Baptist Medical Center.

16 Oct 2007

Discovery of protein that plays a key role in the recycling of iron from blood

Scientists working in the only lab at MIT doing hematology research have uncovered a protein that plays a key role in the recycling of iron from blood. Their work, described in the October 11 Journal of Clinical Investigation, could lead to new therapies for certain inherited blood disorders such as beta-thalassemia, a condition that causes chronic anemia.

12 Oct 2007

Anticlotting drug found to be safe in sickle cell patients

An intravenous "blood thinner" widely used in patients with acute coronary syndromes and during coronary artery stent placement appears to be safe in patients with sickle cell disease and may have beneficial anti-inflammatory effects, a small study at the University of North Carolina at Chapel Hill School of Medicine has found.

12 Oct 2007

$Accentia announces investigational new drug application for Revimmune for refractory MS$

Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia Biopharmaceuticals has announced that it met with the Food and Drug Administration (FDA) on September 26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune.

10 Oct 2007

Colonoscopy most effective screening option for colon cancer

According to the American Society for Gastrointestinal Endoscopy (ASGE), colonoscopy remains the most effective screening option for colorectal cancer.

3 Oct 2007

Discovery of structure in malaria with potential for a vaccine target

Researchers at the Swedish medical university Karolinska Institutet (KI) and the Swedish Institute for Infectious Disease Control (SMI) have identified the biochemical mechanism behind the adhesive protein that give rise to particularly serious malaria in children.

25 Sep 2007

WHO essential emergency training to save lives and prevent disability

WHO is expanding its programme to train health care staff in low- and middle-income countries in essential emergency, basic surgery and anaesthesia skills.

25 Sep 2007

Experts discuss pioneering non-invasive test to determine the blood type of unborn babies

Experts from across the world will meet to discuss the implementation of a pioneering non-invasive test to determine the blood type of unborn babies at an event hosted by the University of Warwick.

25 Sep 2007